SNCA and Parkinson disease: This review describes coenzyme Q10, mitochondrial ubiquinone-NADH oxidoreductase, melatonin, α-synuclein index, Charnoly body, and metallothioneins as novel biomarkers to confirm PD for early and effective treatment of the disease.